reviewed the experience at our institution and affiliated regional hospitals over the past 16 years. Our goal was to compare two groups of patients with CBTs: those with tumors discovered by palpation (designated Group 1), and those whose tumors were first identified by duplex scanning or through some other imaging modalities (designated Group 2) during diagnostic work-ups for the presence of local symptoms or other associated diseases.
METHODS
The medical records of patients diagnosed with CBTs between 1981 and 1997 at a number of teaching hospitals affiliated with the University of Arizona, the Good Samaritan Hospital of Phoenix, and the Mayo Clinic/Scottsdale were reviewed. Information was obtained by direct communication with surgeons at these medical facilities who had experience treating CBTs during the study period. In addition to the practitioners' data files, hospital records were consulted when they were available. Two groups of patients were identified on the basis of the mode of detection of their tumor: Tumors discovered on physical examination were classified as Group 1, whereas those found incidentally on duplex scanning, computed tomography (CT), or magnetic resonance imaging (MRI) were classified as Group 2. One 2-cm tumor was found incidentally at autopsy and excluded from further analysis. Tumor size, the use of preoperative embolization, the incidence of neurologic complications (stroke, cranial nerve injuries), recurrence, and metastasis were noted for each group. The Shamblin classification was used to assess the difficulty of surgical resection: class 1 lesions consisted of tumors easily isolated and dissected from the carotid vessels; class 2 CBTs were more adherent to the adventitial layer and partially encircled the vessels at the bifurcation; and class 3 lesions were densely adherent to the carotid vessels and completely encircled the carotid bifurcation. 17 
RESULTS
Over the 16 years of this study, 31 patients with a total of 32 CBTs were available for review. Of these patients, 15 were men and 16 were women, and the mean age was 48 years (range, 32-90 years). Ten tumors were located on the right side and 22 on the left; one patient had bilateral chemodectomas. Comorbid conditions are listed in Table I .
In Group I (n = 23), the presence of a neck mass had prompted the patient to seek medical attention in 18 instances; 5 tumors in Group I had been discovered on physical examination by a physician. No exact information could be obtained regarding the time interval between the initial discovery of the mass and the subsequent operative management. In Group 2 (n = 9), the tumors were first detected through use of an imaging modality; eight of these tumors were discovered incidentally on duplex scanning (Fig. 1) performed to rule out carotid artery occlusive disease or vertebrobasilar insufficiency, and one tumor was first detected on MRI during evaluation of a palpable contralateral CBT. Tumor size was determined by physical examination in 15 of 23 patients in Group I and by duplex scanning in the remaining 8 patients. There appeared to be a good correlation between values obtained clinically and measurements of the pathologic specimens. The mean size of the CBTs in Group 1 was 4.3 ± 1.7 cm; this compares with 2.7 ± 1.0 cm for Group 2 (p = 0.007, by paired t test). None of the patients in either group manifested preoperative focal neurologic symptoms. All neurologic complications occurred in the perioperative period and were related to preoperative embolization, intraoperative manipulation of the carotid artery, or injury to adjacent cranial nerves.
Preoperative evaluation and management
Imaging modalities performed included duplex scanning (9) , CT (4), and MRI (2) . A cerebral angiogram was obtained in all cases before surgery (Fig. 2) , with the exception of one patient who had CT angiography (Fig. 3) . Preoperative embolization was performed at the discretion of the surgeon in six Group I patients (mean tumor size before embolization, 5 cm; range, 4.3-6 cm) and no patients in Group 2. Obliteration of the microvasculature of the CBTs was felt to be successful in five cases on the basis of completion studies. In one instance the procedure was terminated prematurely when the patient complained of an acute ipsilateral visual deficit.
Operative procedure
The patient is positioned supine, with the neck rotated to the opposite side. Because the need for carotid resection cannot always be predicted, one leg is prepared in all procedures in case the saphenous vein should be required. The carotid artery is exposed through a standard anterolateral cervical incision along the anterior border of the sternocleidomastoid muscle. Control of the common, internal, and external carotid arteries is obtained, and the hypoglossal and vagus nerves are identified. Through use of bipolar diathermy a dissection plane is established at the inferior margin of the tumor at the bifurcation and extended cephalad onto the internal and external carotid arteries. Branches of the external carotid artery may require division to facilitate the dissection. This technique is usually adequate for excision of Shamblin 1 and 2 CBTs. Tumors completely encasing or infiltrating the internal carotid artery (class 3) are often managed by resection of the involved portion of the artery and replacement with a saphenous interposition vein graft. It may be necessary to mobilize the parotid gland and divide the digastric and stylohyoid muscles to facilitate exposure for tumors extending to the base of the skull.
Operation on patients who had undergone preoperative embolization was usually undertaken within 24 to 48 hours. At surgery, 10 tumors were classified as Shamblin class 1, 15 as class 2, and 6 as class 3 (Table II ). An indwelling carotid artery shunt placed through the vein graft was used to facilitate the distal anastomosis in three instances. Complete excision of the tumor was accomplished in 29 of 31 cases.
Residual tumor was present in each of two Group 1 cases because the operating surgeon believed that the extensive resection required to remove all obvious tumor was not justified. The external carotid artery was ligated in nine cases, and internal carotid artery reconstruction (seven nonreversed saphenous interposition veingrafts and one expanded polytetrafluoroethylene patch angioplasty) was needed in eight cases (Table II) . One patient received a 1-unit transfusion of red blood cells.
No perioperative mortality was observed in either group. The average postoperative follow-up was 3.2 years.
Neurologic complications
In Group 1, one patient had a stroke after preoperative embolization; a second patient had a postoperative aphasia, presumably because of embolization from unrecognized carotid disease that partially resolved. Three patients sustained cranial nerve injuries during resection of their tumors: injury to the mandibular branch of the facial nerve was observed in one of these three patients, resection of segments of the IX, X, and XII cranial nerves was necessary to permit complete removal of an invasive neoplasm in another, and injury to the hypoglossal nerve occurred in the third. This last patient subsequently underwent radiation therapy, but the tumor recurred in 1993 and has extended to the base of the skull with metastasis to the brain, which has resulted in multiple cranial nerve palsies. This was the only case in our series in which a definite proof of malignancy could be established because of the presence of metastasis.
In Group 2, one patient sustained an injury to the hypoglossal nerve during excision of a 4 × 3-cm CBT that, despite its size, had been missed on clinical examination and was first diagnosed by duplex scanning.
DISCUSSION
Carotid body tumors are uncommon lesions. Since the report by Marchand 18 in 1891, there have been a number of sporadic reports in the literature. Approximately 1000 cases had been reported by 1990. 19 The Mayo Clinic reported one of the largest series to date, describing 153 cases over a 50-year period. 6 Carotid body tumors are seen in most series with roughly the same frequency in male and female patients; they primarily occur in the fifth decade of life, although studies of CBTs occurring at high altitude have noted a marked predilection for female patients. 20 Cases can be sporadic or familial; in familial series, they are often bilateral-either synchronous or metachronous-and may be associated with other paragangliomas as well as coagulation disorders. 21 All of the cases evaluated in this study were sporadic and had no apparent relationship to high altitude. Macroscopically CBTs usually have a meaty, light tan appearance, but they may appear congested or frankly hemorrhagic as a result of surgical manipulation. Necrosis is usually rare except after successful preoperative embolization. Histologically the (Fig.  4) . However, most CBTs appear to be nonsecreting. 22 Earlier histologic studies 23 based on mitotic activity, capsular invasion, and cellular pleomorphism suggested that up to 50% of these 10 lesions were malignant. More recent studies 5,24-26 have estimated the incidence of malignancy to be between 5% and 10%. Aggressive local invasion with encir- clement of the carotid vessels may suggest the presence of a cancerous lesion; however, documentation of metastasis to regional lymph nodes, liver, or lungs is usually required for a CBT to be designated as malignant.
Lack of preoperative diagnosis has been reported in up to 30% of patients 20 with CBTs. The usual presentation is a slow-growing mass at the angle of the mandible. Sometimes these tumors are confused with enlarged lymph nodes, branchial cysts, salivary glands, carotid aneurysms, or neurofibromas, and the patients are consequently subjected to unwise attempts at biopsy or exploratory surgery. Two patients in this study underwent preoperative biopsies: one had a fine-needle biopsy suggestive of malignancy and the other had an open biopsy rapidly terminated because of excessive bleeding. The presence of a symptomless mass in the anterior triangle of the neck should alert the examiner to the possibility of a CBT. A useful clinical sign in differentiating a CBT from other lesions is Fontaine's sign: a carotid body tumor can usually be displaced laterally but not vertically. Lateral displacement results in movement of the common carotid pulse in the same direction as the tumor.
The advent of new imaging technologies potentially allows the detection of CBTs at an earlier stage, before they become palpable. In our study, tumors first detected on imaging studies were statistically smaller (4.3 vs 2.7 cm) than those detected on physical examination. Eight of the tumors were first discovered incidentally by duplex imaging in 11 patients being evaluated for carotid artery occlusive disease. Several small series have now reported improved sensitivity and specificity of duplex ultrasound in identifying CBTs. 16, [27] [28] [29] [30] [31] Typical features include the presence of a solid hypoechoic vascular mass that on Doppler frequency analysis may show a low-resistance arterial flow pattern. 16 In our series, B-mode imaging with color flow Doppler of the carotid vessels first identified a tumor at the carotid bifurcation in eight cases (Fig. 1) . This imaging modality may allow exclusion of other tumorous or vascular entities that could be mistaken for carotid body tumors; the performance of ill-advised biopsy procedures could thus be avoided. 12 Duplex scanning currently appears to be the most useful screening test both in sporadic and familial cases for early detection and diagnostic confirmation of the presence of CBTs. CT or MRI scans are useful in assessing the extent of the neoplasm, its relationship with the carotid arteries and adjacent structures, and the presence of metastases. Although July 1998 conventional angiography yields a characteristic appearance (Fig. 2) , its routine use may be limited in the future to those patients with indeterminate findings on duplex scan, CT, or MRI and aimed at providing access for preoperative embolization, if the surgeon so elects. All but one of the patients in our series had cerebral angiograms; in the remaining patient, both carotid arteries and the tumor were clearly delineated on CT angiogram (Fig. 3) , which allowed surgical resection without angiography.
Available reports 32, 33 suggest that small tumor size permits easier removal and a lower incidence of operative complications, particularly cranial nerve injuries. Davidge-Pitts and Pantanowitz 26 showed a positive correlation between the size of the tumor and the Shamblin classification as determined intraoperatively. In their study, tumors 4 cm or greater in diameter more commonly encircled the carotid arteries either partially (Shamblin class 2) or completely (class 3). In our series, when Group I and Group II tumors were compared with regard to Shamblin classification, no class 3 tumors were found among the smaller Group II tumors. The surgical procedure appeared to have been technically easier in Group II; neither internal carotid artery reconstruction nor external carotid artery ligation were necessary in any Group II patient (Table II) . Our series also showed that more neurologic complications were observed in the group of patients with larger tumors. Actually, the one cranial nerve injury observed in Group II occurred during removal of a 4 × 3-cm chemodectoma that despite its size had been missed on clinical examination and was first detected on duplex scan. All nerve injuries occurred in chemodectomas that were at least 4 cm in diameter.
The discovery of small tumors on imaging studies sometimes creates a dilemma: should a very small tumor be resected or not? A 0.9 × 0.5-cm tumor was detected by duplex scanning in the present study. Because of the patient' s age (77 years) and the size of the lesion, it was elected to treat her conservatively with annual duplex surveillance. Farr 32 has estimated the growth rate of these lesions at about 0.5 cm per year. In view of the relative slow growth of these lesions, it may be feasible to follow selected patients with duplex scanning at 6-month to 12-month intervals.
The routine use of preoperative tumor embolization has been questioned because of the potential neurologic complication associated with the accidental reflux of particulate matter into the ophthalmic or cerebral circulation. 31 Some authors advocate its use before the resection of large tumors because it may decrease the vascularity of the tumor, reducing 9, 34 intraoperative blood loss and transfusion requirements. This adjunctive procedure was successfully performed in 5 of 6 cases in Group I, with a mean tumor size of 5 cm. The remaining patient sustained an ipsilateral stroke during embolization. Although the surgeons using preoperative embolization commented that blood loss was reduced, in fact only one patient in the study received a blood transfusion. We believe that the apparent benefits of embolization should be weighed against the risk of stroke and that its current use be limited to tumors greater than 5 cm in diameter. The early detection and resection of smaller lesions therefore appears to provide an additional advantage by decreasing the need for preoperative embolization and its attendant risks.
Another unresolved therapeutic issue is the beneficiality of radiotherapy on these tumors. Radiotherapy has been used in patients with metastatic lesions or lesions presumed to be malignant. Although some reports 35, 36 have indicated that such tumors were radioresistant, other reports 5 have shown that radiotherapy can result in regression of these tumors in some instances; however, after initial control, recurrence has been observed. 8 The only patient treated by adjuvant radiation therapy in our series later manifested local recurrence and regional metastasis.
CONCLUSION
The rationale for aggressive surgical excision of CBTs was initially based on early data suggesting that up to 50% of these paragangliomas were malignant. The subsequent recognition that these lesions were slow-growing and rarely malignant and that surgical therapy was often associated with local (cranial nerve) complications led some authors to recommend careful observation of these lesions. Recent series advocate resection of all tumors once they are discovered in appropriate patients. The increasing use of newer imaging modalities, particularly duplex scanning, may allow earlier detection of CBTs and hence safer operations. The eight patients whose CBTs were detected by imaging modalities had the same morality rate (0%) as, and a lower incidence of cranial nerve injury than, those patients whose tumors had been detected clinically. Furthermore no patient in the former group required external carotid artery ligation or internal carotid artery replacement. Duplex scanning may be used to follow tumor growth in poor-risk patients with small tumors, although this algorithm remains unproven. July 1998 Dr. Ralph B. Dilley (San Diego, Calif.). I congratulate Dr. Westerband and his colleagues for a nice presentation and for reviewing a large series of patients with carotid body tumors, which were treated in a contemporary time frame. As the authors indicate, some series in the literature studied more patients with these rare tumors, but these reports spanned more years and most often treated the patients without the benefit of modern techniques of evaluation and management.
The major thrust of the presentation is that if these tumors are discovered early, when small, then, resection is accomplished without the known high incidence of operative stroke or, more particularly, cranial nerve damage.
The authors divided patients into two groups. The first group consisted of tumors discovered when a neck mass prompted evaluation; the second consisted of patients with tumors discovered by an imaging technique, which was used to investigate other conditions, most often the question of carotid artery disease. The results lend support to the view that all tumors should be resected, particularly when small, because the incidence of neurologic complications are fewest when small tumors were resected. In this series, 5 of 23 patients had neurologic complications when operations were performed for clinically evident tumors. Only 1 patient in 8 had a neurologic complication when tumors were discovered by an imaging technique and were not clinically evident. In all cases with neurologic complications, the size of the tumor exceeded 4 cm.
The authors also indicate important principles in the modern management of these tumors. These include the following principles: the role of duplex scanning in diagnosis and screening; the role of computed tomography scanning or magnetic resonance imaging if there is a question of multiplicity; the necessity for preoperative neurologic assessment, particularly cranial nerve function; the importance of preparing the thigh for a vein graft if the tumor is large or it is suspected that the tumor encompasses the internal carotid artery (known as Shamblin Type III tumors); the importance of the use of a bipolar cautery to avoid heat injury to nerves; and finally, details of dissection including the necessity of dissection in the adventitial plane for larger tumors.
In spite of these generally accepted principles of management, there remain several controversial areas. This fact prompts the following questions:
1. Because carotid body tumors generally are recognized to be familial, do you recommend screening relatives of patients with these lesions? Which relatives would you screen? 2. Is duplex scanning for anatomic detail accurate enough so that angiography is not necessary? All of your patients but one had both duplex scan studies and angiography. In answer to the first question, most chemodectomas appear sporadically in about 70% to 80% of the cases. However, there are some familial cases, and in these cases, it has been shown that bilaterality is common.
Should we scan the relatives of patients with carotid body tumors? I do not have any strong data to support that suggestion, but I would tend to say yes. Brothers and sisters should be screened for the presence of carotid body tumor, especially if they have a small lump in the neck.
Is duplex scanning accurate enough? I believe duplex scanning is certainly accurate enough to make a diagnosis of carotid body tumors. One of the typical findings on duplex scan is low arterial resistance of the flow pattern within the carotid body tumors.
To my knowledge, there is no neoplasm other than a carotid body tumor that occurs in the carotid bifurcation. For a small tumor that is 2 cm or less in size, a duplex scan alone probably can establish the diagnosis well enough to proceed with the resection.
Your third question asked when to perform preoperative embolization. According to the literature, advocates of preoperative embolization require a tumor that measures 3 cm or larger. Obviously, there is a risk attached to performing the preoperative embolization. Because of this risk, some authors do not recommend embolization at all.
In answer to your fourth question, a shunt was used in only three patients. Those patients had a mean age of 48 years, therefore, we did not measure the back pressure. Many of them were young, between 30 and 50 years of age.
Your last question asked what size tumor to resect. We should resect all tumors unless the tumor is small and the patient has coexisting medical conditions that would increase operative risks.
Dr. Tammy Ramos (Omaha, Neb.). I enjoyed your review, Dr. Westerband. We recently reviewed our experience at the University of California at San Francisco over a contemporary 10-year period to assess whether preoperative embolization was necessary. There were 23 patients in our review. Of those patients, 11 had preoperative embolization and 12 did not. The median tumor size was 4 to 5 cm in this group of patients. We found no difference in outcome with respect to operative technique, blood loss, and time in those two groups of patients. The only significant difference that we found was in length of hospitalization. The length of stay was longer in the group that was embolized.
Dr. Westerband. Thank you for your comments.
